Alcidion Group Limited (ASX:ALC) is pleased to advise, in accordance with ASX Listing Rule 3.13.2 and Section 251AA of the Corporations Act, details of the resolutions and proxies received for the Extraordinary General Meeting held on 14 June 2018.
Resolution 1 was passed with voting conducted by poll. Proxies received and the results of the poll are shown in the Schedule below.
Extraordinary General Meeting Results
Thursday, 14 June 2018
As required by section 251AA(2) of the Corporations Act 2001 (Commonwealth) the following statistics are provided in respect of each resolution on the agenda.
** Note that votes relating to a person who is Excluded on an item are not counted in determining whether or not the required majority of votes were cast for or against that item
### ENDS ###
For further information, please contact:
Kyahn Williamson, WE Buchan
Ph: 0401018828 or +61 3 9866 4722
Alcidion Group Limited (ASX:ALC) is a publicly listed, innovative health informatics company that specializes in clinical products that improve productivity, safety and efficiency. Alcidion’s solutions target key problems for Emergency Rooms, Inpatient Services and Outpatient Departments and are built upon a next generation health informatics platform, which incorporates an intelligent EMR, Clinical Decision Support Engine, Data Integration Capability, Smartforms, Terminology Support and Standards Based Web Services.
Alcidion’s focus is on delivering solutions that enable high performance healthcare and which assist clinicians by minimising key clinical risks, tracking patient progress through journeys and improving quality and safety of patient care.